SCHEMBL6921048

SCHEMBL6921048

Oc1cccc2c1c1cc(F)ccc1n2Cc1ccc(F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
MAPT P10636 6/20 0.42
GAA P10253 2/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LMNA P02545 1/20 0.41
SRC P12931 1/20 0.41
TP53 P04637 1/20 0.41
KDM4E B2RXH2 4/20 0.40
PKM P14618 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
CRY1 Q16526 1/20 0.40
CRY2 Q49AN0 1/20 0.40
HK1 P19367 1/20 0.40
HTT P42858 1/20 0.40
HKDC1 Q2TB90 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6923669 0.93 SRC (0.50) HDAC1HDAC8HDAC6MAPTGAA
SCHEMBL6926577 0.91 MAPT (0.43) MAPTGAAMEN1ALDH1A1KMT2A
SCHEMBL6923683 0.90 KDM4E (0.44) MAPTMEN1ALDH1A1KMT2ALMNA
SCHEMBL7505287 0.83 ESR1 (0.44) MAPTMEN1KMT2AKDM4EPKM
SCHEMBL6921052 0.80 MEN1 (0.43) MAPTGAAMEN1ALDH1A1KMT2A
SCHEMBL7723992 0.79 SRC (0.53) MAPTGAAMEN1ALDH1A1KMT2A
SCHEMBL6924605 0.78 MEN1 (0.43) HDAC1HDAC8HDAC6MAPTGAA
SCHEMBL6924327 0.78 SRC (0.51) HDAC1HDAC6MAPTMEN1ALDH1A1
SCHEMBL6926616 0.77 LMNA (0.44) MAPTGAAMEN1ALDH1A1KMT2A
SCHEMBL6923659 0.77 KMT2A (0.51) MAPTGAAMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1169789-C Aminoalkoxy carbazoles for the treatment of CNS diseases 法玛西雅厄普约翰美国公司 2004-10-06 CN disclosed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
CN-1372547-A Aminoalkoxy carbazoles for the treatment of CNS diseases UPJOHN CO (US) 2002-10-02 CN disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed